Phase II/III Study Trends and Market Outlook (2016-2020)

Report Overview

In much of our research, we make a point to ask respondents for their outlook on market changes or trends they expect to occur regarding a specific topic. To this end, ISR dedicated a research effort to providing a broad view into the industry’s perspectives on the clinical development market. For this report, 112 Phase II/III decision-makers were surveyed to gather their insights into where the Phase II/III market is expected to head over the next four years. This report is designed to assist those interested in the Phase II/III market in not only remaining current with market happenings but in getting a jump on what the market is expected to look like in 2020.

What you will learn:

• 4-year examination of the industry’s Phase II/III market dynamics (i.e. study volume, outsourced spend)
• Average dollar value of outsourced Phase II/III studies and how this varies by sponsor size
• Criteria sponsors use to select (and disqualify) clinical service providers
• Current and future use of adaptive trials and risk-based monitoring in Phase II/III trials

How you can use this report:

• Gain understanding of the key decision-makers within sponsor organizations to develop more targeted communications
• Learn the most desirable characteristics of a Phase II/III service provider
• Discover the expansion into developing markets